A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

692

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2
COVID-19

Interventions

BIOLOGICAL: CV0701 mRNA COVID-19 Vaccine (Low dose)
BIOLOGICAL: CV0701 mRNA COVID-19 Vaccine (Medium dose)
BIOLOGICAL: CV0701 mRNA COVID-19 Vaccine (High dose)
BIOLOGICAL: CV0601 mRNA COVID-19 Vaccine
BIOLOGICAL: Control vaccine
BIOLOGICAL: CV0801 mRNA COVID-19 Vaccine

Sponsor

GlaxoSmithKline

Collaborators

[object Object]